Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Effectiveness and Safety of a New Methotrexate Regimen in Treatment of Undisturbed Tubal Ectopic Pregnancy : A Pilot Prospective Study

ID
Name
Ectopic tubal pregnancy
Description
Evaluate the efficacy and safety of the use of low dose regimen of methotrexate in treatment of tubal undisturbed tubal ectopic pregnancy
Trial arms
Trial start
2024-03-01
Estimated PCD
2025-03-01
Trial end
2025-03-01
Status
Not yet recruiting
Treatment
Methotrexate
use low dose of Methotrexate in treatment of un distectopic tubal pregnancy
Size
20
Primary endpoint
descriptive measurements of the results of using low dose methotrexate regimen in treatment of tubal undisturbed ectopic pregnancy
7 day
Eligibility criteria
Inclusion Criteria: * undisturbed ectopic tubal pregnancy Bhcg \< 5000 * Haemodynamicaly stable * Normal liver and kidney functions * Commitment for fullow up untill ectopic pregnancy resolvede Exclusion Criteria: * disturbed ectopic pregnancy * Bhcg \>5000 * Persistent abdominal pain * Lactating women * women with abnormal liver and kidney functions
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'OTHER', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 20, 'type': 'ESTIMATED'}}
Updated at
2024-03-08

1 organization

1 product

1 indication

Organization
Assiut University
Product
Methotrexate
Indication
Ectopic Pregnancy